Equities

Alliance Pharma PLC

APH:LSE

Alliance Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)42.55
  • Today's Change-0.95 / -2.18%
  • Shares traded1.63m
  • 1 Year change-5.34%
  • Beta0.8318
Data delayed at least 15 minutes, as of Oct 04 2024 16:35 BST.
More ▼

Profile data is unavailable for this security.

About the company

Alliance Pharma plc is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments include Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include the Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Aloclair Plus Spray, Aloclair Plus Mouthwash, Anbesol Adult Strength Gel, Anbesol Teething Gel, Anbesol Liquid, Atopiclair Cream, and Atopiclair Lotion. It holds marketing rights to around 80 consumer healthcare brands and prescription medicines, which are sold worldwide in more than 100 countries.

  • Revenue in GBP (TTM)183.15m
  • Net income in GBP-33.58m
  • Incorporated2001
  • Employees290.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Cipher Pharmaceuticals Inc16.89m17.22m226.30m9.00226.30m9.00
Themis Medicare Ltd37.02m4.54m226.47m1.54k226.47m1.54k
VIVA Biotech Holdings216.63m-34.53k228.60m2.04k228.60m2.04k
Aurora Cannabis Inc156.48m-16.71m228.80m1.07k228.80m1.07k
Alliance Pharma plc183.15m-33.58m230.01m290.00230.01m290.00
Natac Natural Ingredients SA38.23m7.36m232.84m172.00232.84m172.00
PharmaSGP Holding SE91.83m15.24m232.93m93.00232.93m93.00
Golden Throat Holdings Group Co Ltd109.25m28.47m233.63m860.00233.63m860.00
Data as of Oct 04 2024. Currency figures normalised to Alliance Pharma PLC's reporting currency: UK Pound GBX

Institutional shareholders

39.10%Per cent of shares held by top holders
HolderShares% Held
Slater Investments Ltd.as of 22 Jul 202470.68m13.08%
Rathbones Investment Management Ltd.as of 06 Oct 202325.97m4.81%
Fidelity Management & Research Co. LLCas of 11 Jun 202419.64m3.64%
Artemis Investment Management LLPas of 11 Jun 202417.35m3.21%
Van Lanschot Kempen Investment Management NVas of 18 Jun 202415.02m2.78%
RBC Global Asset Management (UK) Ltd.as of 25 Aug 202314.55m2.69%
Rowan Dartington & Co. Ltd. (Broker)as of 01 Jun 202414.44m2.67%
Brooks Macdonald Asset Management Ltd.as of 01 Jun 202411.93m2.21%
Polar Capital LLPas of 01 Jun 202411.21m2.08%
Bill & Melinda Gates Foundation Trust (Investment Management)as of 01 Jun 202410.50m1.94%
More ▼
Data from 31 Jan 2024 - 01 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.